Search Results - Yuntao Jia

Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system by Jing Huang, Yuntao Jia, Shusen Sun, Long Meng

Connect to this object online.

Quality assessment of paediatric randomized controlled trials published in China from 1999 to 2022: a cross-sectional study by Bennian Huo, Song Xu, Yao Liu, Lin Su, Yuntao Jia, Maolin Ai, Nange Yin, Lin Song

Connect to this object online.

Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system by Hongli Wang, Hongli Wang, Guizun Zhong, Guizun Zhong, Huanhuan Ji, Siqi Chen, Qinqin Xie, Zhengze Shen, Yuntao Jia

Connect to this object online.

Current situation of pediatric clinical trials in China: focus on trials for drug marketing application and administrative approval by Lin Song, Yuntao Jia, Sujuan Ran, Bin Li, Jin Xu, Bennian Huo, Nange Yin, Maolin Ai, Yao Liu

Connect to this object online.

Predicting Adverse Drug Events in Chinese Pediatric Inpatients With the Associated Risk Factors: A Machine Learning Study by Ze Yu, Huanhuan Ji, Jianwen Xiao, Ping Wei, Lin Song, Tingting Tang, Xin Hao, Jinyuan Zhang, Qiaona Qi, Yuchen Zhou, Fei Gao, Yuntao Jia

Connect to this object online.

Guideline for the management of pediatric off-label use of drugs in China (2021) by Min Meng, Enmei Liu, Bo Zhang, Quan Lu, Xiaobo Zhang, Bin Ge, Ye Wu, Li Wang, Mo Wang, Zhengxiu Luo, Ziyu Hua, Xiaoling Wang, Wei Zhao, Yi Zheng, Xinan Wu, Ruiling Zhao, Wenbo Meng, Li Xiang, Gang Wang, Yuntao Jia, Yongchuan Chen, Xiaoyan Dong, Lina Hao, Chengjun Liu, Meng Lv, Xufei Luo, Yunlan Liu, Quan Shen, Wenjuan Lei, Ping Wang, Yajia Sun, Juanjuan Zhang, Ling Wang, Ruobing Lei, Tianchun Hou, Bo Yang, Qiu Li, Yaolong Chen

Connect to this object online.